Immunity stack
KPV + BPC-157 + TB-500 — inflammation control & repair
2.583.000 ₫
Vial-by-vial breakdown
A three-peptide protocol pairing deep anti-inflammatory control with tissue repair. KPV (α-MSH tripeptide) suppresses NF-κB signalling and pro-inflammatory cytokines, calming gut and systemic inflammation. BPC-157 protects the gut lining, drives angiogenesis and accelerates tendon, ligament and GI repair. TB-500 mobilises stem cells and reduces inflammation across soft tissue. Together the stack targets the two axes most often compromised during post-antibiotic recovery, slow-healing wounds, or immune-driven inflammation: inflammatory control and tissue rebuild. Typically run as a 4–8 week protocol around immune stress, post-illness recovery, or chronic gut/skin inflammation.
Dosage
KPV: 0.5mg/day · BPC-157: 0.25–0.5mg/day · TB-500: 2.5mg 1–2× weekly
Duration of effect
Daily dosing; benefits build over weeks (varies by component)
See full half-life table →Key Features
- Innate antimicrobial defence
- Gut & systemic anti-inflammatory
- Tissue repair & angiogenesis
- 10% stack discount
Includes key details, half-life data, usage notes and research sources.
Usage Instructions
Subcutaneous or intramuscular injection. May be split into multiple smaller doses throughout the day. Consult a specialist for personalized protocols.
Research Highlights
- Backed by scientific research
- Manufactured to pharmaceutical standards
- Used in clinical research settings
- Established safety profile
Safety Information
- •Consult your healthcare provider before use
- •Not intended for pregnant or nursing women
- •Store properly according to instructions
- •Report any adverse effects to your healthcare provider
Source: Inflammatory Bowel Diseases — ResearchGate
Clinical Research
KPV has anti-inflammatory potential in murine models of inflammatory bowel disease, significantly reducing inflammatory infiltrates and MPO activity — the gut/inflammation pillar of the Immunity stack.
Read full study